Gellan gum injectable hydrogels for cartilage tissue engineering applications: in vitro studies and preliminary in vivo evaluation.

Gellan gum is a polysaccharide that we have previously proposed for applications in the cartilage tissue engineering field. In this work, gellan gum hydrogels were tested for their ability to be used as injectable systems using simple processing methods, able to deliver and maintain chondrocytes by in situ gelation, and support cell viability and production of extracellular matrix (ECM). Rheological measurements determined that the sol-gel transition occurred near the body temperature at 39 degrees C, upon temperature decrease, in approximately 20 s. Gellan gum discs shows a storage compression modulus of around 80 kPa at a frequency of 1 Hz by dynamic mechanical analysis. Human articular chondrocytes were encapsulated in the gels, cultured in vitro for total periods of 56 days, and analyzed for cell viability and ECM production. Calcein AM staining showed that cell kept viable after 14 days and the histological analysis and real-time quantitative polymerase chain reaction revealed that hyaline-like cartilage ECM was synthesized. Finally, the in vivo performance of the gellan gum hydrogels, in terms of induced inflammatory reaction and integration into the host tissue, was evaluated by subcutaneous implantation in Balb/c mice for 21 days. Histological analysis showed a residual fibrotic capsule at the end of the experiments. Dynamic mechanical analysis revealed that the gels were stable throughout the experiments while evidencing a tendency for decreasing mechanical properties, which was consistent with weight measurements. Altogether, the results demonstrate the adequacy of gellan gum hydrogels processed by simple methods for noninvasive injectable applications toward the formation of a functional cartilage tissue-engineered construct and originally report the preliminary response of a living organism to the subcutaneous implantation of the gellan gum hydrogels. These are the two novel features of this work.

[1]  Alan M. Smith,et al.  Degradation of polysaccharide hydrogels seeded with bone marrow stromal cells. , 2011, Journal of the mechanical behavior of biomedical materials.

[2]  M. S. Kallos,et al.  Optimizing gelling parameters of gellan gum for fibrocartilage tissue engineering. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

[3]  J T Oliveira,et al.  Polysaccharide‐based materials for cartilage tissue engineering applications , 2011, Journal of tissue engineering and regenerative medicine.

[4]  R. L. Reis,et al.  Gellan gum‐based hydrogels for intervertebral disc tissue‐engineering applications , 2011, Journal of tissue engineering and regenerative medicine.

[5]  Ali Khademhosseini,et al.  Modified Gellan Gum hydrogels with tunable physical and mechanical properties. , 2010, Biomaterials.

[6]  M. Gomes,et al.  Injectable gellan gum hydrogels with autologous cells for the treatment of rabbit articular cartilage defects , 2010, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  R L Reis,et al.  Gellan gum: a new biomaterial for cartilage tissue engineering applications. , 2009, Journal of biomedical materials research. Part A.

[8]  Dong-An Wang,et al.  An improved injectable polysaccharide hydrogel: modified gellan gum for long-term cartilage regeneration in vitro , 2009 .

[9]  R. Reis,et al.  Injectable gellan gum hydrogels as supports for cartilage tissue engineering applications , 2008 .

[10]  Yvonne Perrie,et al.  An Initial Evaluation of Gellan Gum as a Material for Tissue Engineering Applications , 2007, Journal of biomaterials applications.

[11]  C. Brew,et al.  SOX9 transduction of a human chondrocytic cell line identifies novel genes regulated in primary human chondrocytes and in osteoarthritis , 2007, Arthritis research & therapy.

[12]  R. Reis,et al.  Osteochondral defects: present situation and tissue engineering approaches , 2007, Journal of tissue engineering and regenerative medicine.

[13]  Boon Chin Heng,et al.  Osteoarthritis and therapy. , 2006, Arthritis and rheumatism.

[14]  K. Nishinari,et al.  Effects of molar mass on the coil to helix transition of sodium-type gellan gums in aqueous solutions , 2006 .

[15]  M D McKee,et al.  Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle. , 2005, Osteoarthritis and cartilage.

[16]  C. M. Alves,et al.  Production and characterization of chitosan fibers and 3-D fiber mesh scaffolds for tissue engineering applications. , 2004, Macromolecular bioscience.

[17]  Lori A. Setton,et al.  Photocrosslinkable Hyaluronan as a Scaffold for Articular Cartilage Repair , 2004, Annals of Biomedical Engineering.

[18]  D. Mooney,et al.  Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.

[19]  David Attwood,et al.  Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. , 2003, International journal of pharmaceutics.

[20]  T. Aigner,et al.  SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[21]  Paolo Giannoni,et al.  Tissue engineering and cell therapy of cartilage and bone. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[22]  Marie-Christine Chaboissier,et al.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.

[23]  Makarand V Risbud,et al.  Tissue engineering: advances in in vitro cartilage generation. , 2002, Trends in biotechnology.

[24]  F. Thürmer,et al.  Formation of cartilage matrix proteins by BMP-transfected murine mesenchymal stem cells encapsulated in a novel class of alginates. , 2002, Biomaterials.

[25]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[26]  K. Dickstein,et al.  Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma. , 2001, American journal of ophthalmology.

[27]  A. Hoffman Hydrogels for Biomedical Applications , 2001, Advanced drug delivery reviews.

[28]  W. Knudson,et al.  Cartilage proteoglycans. , 2001, Seminars in cell & developmental biology.

[29]  R. Sanderson,et al.  Heparan sulfate proteoglycans in invasion and metastasis. , 2001, Seminars in cell & developmental biology.

[30]  D. Hutmacher,et al.  Scaffolds in tissue engineering bone and cartilage. , 2000, Biomaterials.

[31]  M. Spector,et al.  Articular cartilage chondrocytes in type I and type II collagen-GAG matrices exhibit contractile behavior in vitro. , 2000, Tissue engineering.

[32]  J. Elisseeff,et al.  Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. , 2000, Journal of biomedical materials research.

[33]  Juming Tang,et al.  Texture properties of high and low acyl mixed gellan gels , 2000 .

[34]  Kevin E. Healy,et al.  Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro , 1999 .

[35]  T Coviello,et al.  A novel co-crosslinked polysaccharide: studies for a controlled delivery matrix. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.

[37]  A Ratcliffe,et al.  Differences in patellofemoral joint cartilage material properties and their significance to the etiology of cartilage surface fibrillation. , 1997, Osteoarthritis and cartilage.

[38]  A I Caplan,et al.  Principles of cartilage repair and regeneration. , 1997, Clinical orthopaedics and related research.

[39]  Arnold I. Caplan,et al.  Overview: Principles of Cartilage Repair and Regeneration , 1997 .

[40]  E. Miyoshi Rheological and thermal studies of gel-sol transition in gellan gum aqueous solutions , 1996 .

[41]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[42]  E. Topp,et al.  Gellan-based systems for ophthalmic sustained delivery of methylprednisolone , 1993 .

[43]  A. Rozier,et al.  Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol , 1989 .

[44]  Per-Erik Jansson,et al.  Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseudomonas elodea , 1983 .

[45]  J. K. Baird,et al.  PS-60: A New Gel-Forming Polysaccharide , 1981 .

[46]  H. Kurz,et al.  Cell-laden and cell-free biopolymer hydrogel for the treatment of osteochondral defects in a sheep model. , 2009, Tissue engineering. Part A.

[47]  S. Dickinson,et al.  Chondrocyte isolation, expansion, and culture on polymer scaffolds. , 2004, Methods in molecular biology.

[48]  A. Crawford,et al.  Methods in Molecular Biology: Biopolymer methods in tissue engineering , 2004 .

[49]  L. Jazrawi,et al.  Arthroscopic management of osteoarthritis of the knee. , 2003, The Journal of the American Academy of Orthopaedic Surgeons.

[50]  M. Iwahashi,et al.  Conformational transition of gellan gum of sodium, lithium, and potassium types in aqueous solutions , 2002 .

[51]  Hirohisa Yoshida,et al.  The conformational properties of gellan gum hydrogels , 1993 .

[52]  O. Smidsrod,et al.  Gelation of gellan gum , 1987 .